| Ticker: | TNDM |
| Current Price: | $16.01 |
| % Daily Change: | -3.84% |
| Volume (1,000s): | 2,221.72 |
| Average Volume (1,000s): | 0.00 |
| Market Cap (M): | $1,097.15 |
| 1/2/2024 Price: | $36.83 |
| Change Since Inception: | -56.53% |
12400 High Bluff Drive
San Diego, CA 92130
United States
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) designs and sells automated insulin delivery systems for people living with diabetes. Its two pumps, the t:slim X2 and the smaller, phone-controlled Tandem Mobi, run on Control-IQ+ technology, which adjusts insulin automatically using readings from integrated continuous glucose monitors from Dexcom and Abbott. Tandem also sells the cartridges and infusion sets its pumps use, along with software for managing therapy data. The company has submitted a tubeless version of Tandem Mobi to the FDA that would let users switch between tubed and tubeless wear on a single pump. Incorporated in 2006, Tandem Diabetes is headquartered in San Diego, California.